Back

Donor-derived cell-free DNA first validated for noninvasive monitoring of acute rejection in an asian heart transplant population

11 May 2026 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: Heart transplantation: risk stratification, rejection mechanisms, and long-term outcomes Heart Transplantation Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mr Zhiyuan Zhu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Single-cell landscapes defines peripheral immune heterogeneity of cardiac allograft rejection subtypes
Mr Z. Zou (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Circulating miRNAs as potential biomarkers of microvascular cardiac allograft vasculopathy after heart transplantation
Doctor I. Just-Lauer (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Left atrial peak reservoir strain and outcomes after heart transplantation
Doctor S. Jeong (Seoul, KR)
Abstract Slides
Presentation thumbnail
Myocardial proteomics identify mitochondrial structural alterations in acute cardiac allograft rejection
Doctor T. Lerchner (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Fear of graft rejection and its relationship to psychological general well-being: a longitudinal five-year follow-up after heart transplantation
Mrs J. Granstrom (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Heart transplantation: risk stratification, rejection mechanisms, and long-term outcomes

The Event

Event poster

Heart Failure 2026

11 May 2026 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Decentralized donor-derived cell-free DNA testing for cardiac allograft rejection: clinical validation and additive value beyond standard-of-care monitoring
thumbnail
Congress Presentation
Donor-derived cell-free DNA as a new biomarker for acute rejection in heart transplant recipients: results from the freedna car study
thumbnail
Congress Presentation
Role of NTproBNP and donor-derived cell-free DNA in the diagnosis of acute rejection in heart transplant recipients: a prospective study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources